Elevance Health, Inc. (ELV) — Stock Price, Chart & Analysis
Elevance Health, Inc. (ELV) is a Healthcare stock currently trading at $394.2, up 0.72% on the day. It carries a market capitalization of $85.49B and a trailing P/E ratio of 17.30. Over the past 52 weeks, ELV has traded between $274.84 and $436.24. Elevance Health, Inc. pays a dividend yielding 1.8%. View the live ELV chart, technical opinion, analyst ratings, fundamentals and latest news below.
Elevance Health, Inc. (ELV) key data
| Price | $394.2 |
| Change (today) | +0.72% |
| Previous close | $391.4 |
| Market cap | $85.49B |
| P/E ratio (TTM) | 17.30 |
| EPS (TTM) | $22.78 |
| Dividend yield | 1.8% |
| 52-week high | $436.24 |
| 52-week low | $274.84 |
| Beta | 0.69 |
| Avg. volume | 1.65M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Frequently asked questions about Elevance Health, Inc. (ELV)
How much does one share of Elevance Health, Inc. cost?
As of the latest update, one share of Elevance Health, Inc. (ELV) trades at $394.2 (+0.72% today).
What is Elevance Health, Inc.'s market cap?
Elevance Health, Inc. has a market capitalization of approximately $85.49B.
What is Elevance Health, Inc.'s P/E ratio?
Elevance Health, Inc. has a trailing price-to-earnings (P/E) ratio of 17.30.
What is Elevance Health, Inc.'s earnings per share (EPS)?
Elevance Health, Inc.'s trailing twelve-month EPS is $22.78.
Does Elevance Health, Inc. pay a dividend?
Yes — Elevance Health, Inc. pays a dividend with a yield of 1.8% ($6.88 per share annually).
What is Elevance Health, Inc.'s 52-week trading range?
Over the past year, ELV has traded between $274.84 and $436.24.
What is the analyst price target for Elevance Health, Inc.?
The mean analyst price target for Elevance Health, Inc. is $449.10. This is informational only and not investment advice.
Latest Elevance Health, Inc. (ELV) news
- Is Elevance Health (ELV) Entering a Major Earnings Recovery?News · Aug 4, 2026
- Is Elevance Health (ELV) Positioned for Margin Recovery?News · Aug 4, 2026
- Elevance Health (ELV) After Its Cancer Care Push, Does The Valuation Still Look Attractive##News · Aug 1, 2026
- Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giantNews · Jul 31, 2026
- Elevance Health Pick of the Week at Smart Insider Following CEO, Chairman Share PurchasesNews · Jul 28, 2026
- UNH Leads Its Peer Group. You Pay For ThatNews · Aug 7, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ELV dashboard…